Conifex Timber Inc. ('Conifex”, 'we” or 'us”) (TSX: CFF) today reported results for the third quarter ended September 30, ...

Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer ...

NXG Cushing® Midstream Energy Fund (SRV) remains a Buy, benefiting from attractive midstream energy valuations and strong ...

Enrollment now underway in second dose-escalation cohort Deep B-cell depletion observed in all patients treated to date who received NKX019 with ...

Q3 2025 Earnings Call November 14, 2025 5:00 AM ESTCompany ParticipantsFrank StoffelClaire-Marie Coste-Lepoutre - CFO & ...

AlTi Global, Inc. (NASDAQ: ALTI) Q3 2025 Earnings Call Transcript November 12, 2025 AlTi Global, Inc. misses on earnings ...

STOUGHTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today reported its financial results for the quarter ended September 30, 2025, and provided a business ...

Researchers at the University of Southampton have identified a new subtype of lymphoma which could pave the way to improved and more targeted treatments for some blood cancer patients.

Highlights for the third quarter of 2025 include: Increase in net interest income of $0.7 million (or 1.7%) over the second quarter of 2025; Increase in tangible common equity per share of common ...

Critics have long questioned Lando Norris' mental fortitude. His win in Brazil should shut them up, and put the F1 title within his reach.

Signed 20 license agreements with new customers in key growth areas since separationPaid down $11 million of debt in the third quarter, bringing total debt repayment to $312 million since separationFi ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.